Thyroid function derangement and childhood obesity: An Italian experience

BMC Endocrine Disorders

Volumn 10, Issue , 2010, Pages

  Grandone, Anna ^a   Santoro, Nicola ^a   Coppola, Filomena ^a   Calabrò, Paolo ^a   Perrone, Laura ^a   del Giudice, Emanuele M ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

THYROTROPIN;

ADOLESCENT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CHILD; CHILDHOOD OBESITY; CONTROLLED STUDY; ENDOCRINE DISEASE; FEMALE; FREE LIOTHYRONINE INDEX; HUMAN; HYPERTHYROTROPINEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; OBESITY; SCHOOL CHILD; SCORING SYSTEM; THYROID FUNCTION; WEIGHT REDUCTION;

EID: 77952808365     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-10-8     Document Type: Article

References (33)

1. Sokol RJ. The chronic disease of childhood obesity: the sleeping giant has awakened. J Pediatr 2000, 136:711-13.
2. Nathan BM, Moran A. Metabolic complications of obesity in childhood and adolescence: more than just diabetes. Curr Opin Endocrinol Diabetes Obes 2008, 15:21-29.
3. Stichel H, l'Allemand D, Gruters A. Thyroid function and obesity in children and adolescents. Horm Res 2000, 54:14-19. 10.1159/000063431, 11182630.
4. Bhowmick SK, Dasari G, Levens KL, Rettig KR. The prevalence of elevated serum thyroid-stimulating hormone in childhood/adolescent obesity and of autoimmune thyroid disease in a subgroup. J Natl Assoc 2007, 99:773-776.
5. Reinehr T, de Sousa S, Andler W. Hyperthyrotropinemia In obese children is reversible after weight loss and is not related to lipids. J Clin Endocrinol Metab 2006, 91:3088-3091. 10.1210/jc.2006-0095, 16684827.
6. Reinher T, Andler W. Thyroid hormones before and after weight loss in obesity. Arch Dis Child 2002, 87:320-323. 10.1136/adc.87.4.320, 12244007.
7. Shalitin S, Yackobovitch-Gavan M, Philip M. Prevalence of thyroid dysfunction in obese children and adolescents before and after weight reduction and its relation to other metabolic paramenters. Horm Res 2009, 71:155-161. 10.1159/000197872, 19188740.
8. Reinher T. Obesity and thyroid function. Mol Cell Endocrinol 2009,
9. Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, et al. Italian crosssectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 2006, 29:581-93.
10. Cole TJ. The LMS method for constructing normalized growth standards. Eur J Clin Nutr 1990, 44:45-60.
11. Zannolli R, Morgese G. Waist percentiles: a simple test for atherogenic disease?. Acta Paediatr 1996, 85:1368-9. 10.1111/j.1651-2227.1996.tb13928.x, 8955469.
12. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and A The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114:555-76. 10.1542/peds.114.2.S2.555, 15286277, National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and A.
13. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976, 51:170-9. 10.1136/adc.51.3.170, 1545912, 952550.
14. Matthews DR, Hosler JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985, 28:412-419. 10.1007/BF00280883, 3899825.
15. Reinehr T, Andler W. Changes in the atherogenic risk factor profile according to degree of weight loss. Arch Dis Child 2004, 89:419-422. 10.1136/adc.2003.028803, 1719907, 15102630.
16. Eliakim A, Barzilai M, Walach B, Nemet D. Should we treat elevated thyroid stimulating hormone levels in obese children and adolescents?. Int J Pediatr Obes 2006, 1:217-221. 10.1080/17477160600805006, 17907328.
17. Reinehr T, Andler W. Thyroid hormones before and after weight loss in obesity. Arch Dis Child 2002, 87:320. 10.1136/adc.87.4.320, 1763034, 12244007.
18. Cetinkaya E, Aslan AT, Vidinlisan S, Ocal G. Height improvement by L-thyroxine treatment in subclinical hypothyroidism. Pediatr Int 2003, 45:534. 10.1046/j.1442-200X.2003.01786.x, 14521527.
19. Wu T, Flowers JW, Tudiver F, Wilson JL, Punyasavatsut N. Subclinical thyroid disorders and cognitive performance among adolescents in the United states. BMC Pediatr 2006, 6:12. 10.1186/1471-2431-6-12, 1459154, 16623938.
20. Kapelari K, Kirchlechner C, Högler W, Schweitzer K, Virgolini I, Moncayo R. Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study. BMC Endocrine Disorders 2008, 8:15. 10.1186/1472-6823-8-15, 2645400, 19036169.
21. Rallison ML, Dobyns BM, Keating FR, Rall JE, Tyler FH. Occurrence and natural history of chronic lymphocytic thyroiditis in childhood. J Pediatr 1975, 86:675. 10.1016/S0022-3476(75)80350-7, 48541.
22. Ortiga-Carvalho TM, Oliveira KJ, Soares BA, Pazos-Moura CC. The role of leptin in the regulation of TSH secretion in the fed state: in vivo and in vitro studies. J Endocrinol 2002, 174:121-125. 10.1677/joe.0.1740121, 12098670.
23. Mantzoros CS, Ozata M, Negrao AB, Suchard MA, Ziotopoulou M, Caglayan S, et al. Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans. J Clin Endocrinol Metab 2001, 86:3284-91. 10.1210/jc.86.7.3284, 11443202.
24. Reinehr T, Isa A, de Sousa G, Dieffenbach R, Andler W. Thyroid hormones and their relation to weight status. Horm Res 2008, 70:51-57. 10.1159/000129678, 18493150.
25. Sreenan S, Cairo JF, Refetoff S. Thyroid dysfunction is not associated with alteration in serum leptin levels. Thyroid 1997, 7:407-409. 10.1089/thy.1997.7.407, 9226211.
26. Mihaly E, Fekete C, Tatro C, Liposits Z, Stopa EG, Lechan RM. Hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the human hypothalamus are innervated by neuropeptide Y, agouti-related protein, and alpha-melanocyte-stimulating hormone. J clin Endocrinol Metab 2000, 85:2596-2603. 10.1210/jc.85.7.2596, 10902813.
27. Syed MA, Thompson MP, Pachucki J, Burmeister LA. The effect of thyroid hormone on size of fat depots accounts for most of the changes in leptin mRNA and serum levels in the rat. Thyroid 1999, 9:503-12. 10.1089/thy.1999.9.503, 10365683.
28. Araujo RL, Andrade BM, da Silva ML, Ferreira AC, Carvalho DP. D2 deiodinase activity at pituitary level, which controls the feedback of T3 on TSH. Am J Physiol Endocrinol Metab 2009, 296:E1157-63. 10.1152/ajpendo.90869.2008, 19208852.
29. Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer DC. Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med 2006, 119:541-51. 10.1016/j.amjmed.2005.09.028, 16828622.
30. Hueston WJ, King DE, Geesey ME. Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism. Clin Endocrinol (Oxf) 2005, 63:582-587. 10.1111/j.1365-2265.2005.02388.x, 16268812.
31. De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resi stance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol 2007, 67:265-269.
32. Kiortis DN, Durack I, Turpin G. Effects of a low-calorie diet on resting metabolic rate and serum triiodothyroxine levels in obese children. Eur J Pediatr 1999, 158:446-450. 10.1007/s004310051117, 10378389.
33. Niedziela M. Subclinical hypothyroidism: dilemmas in the treatment of children. J Endocrinol Invest 2007, 30:529-531.